PCNA and neoplasm: IHC analysis of proliferating cell nuclear antigen (PCNA) revealed that treatment with iRGD-TRP-PK1-RBCVs loaded with Dox or CDDP effectively reduced PCNA expression in tumour tissues (Figure 5D).